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Abstract  
 Bacterial and fungal strains are growing resistance to antibiotics and antifungal agents at 
an alarming rate. According to the Centers for Disease Control and Prevention, over two million 
people in the United States in 2016 were diagnosed with an infection resistant to antibiotics. As 
such, there has been increased interest in natural products as sources of novel compounds that are 
essential to the development of new drugs and treatment methods. Within the environment, there 
are various host-microbe symbioses, one of which is the Trachymyrmex septentrionalis leaf-cutter 
ant community. The microbes in symbioses like the T. septentrionalis community are hypothesized 
to possess the capacity to produce antimicrobial metabolites. Through the activation of silent 
biosynthetic gene clusters, these organisms can be induced to produce these metabolites which can 
then be isolated for potential drug discovery.  
 Following initial screening of fungus garden bacterial extracts from a T. septentrionalis 
community, two bioactive strains, Pseudomonas fluorescens and Delftia tsuruhatensis, were 
selected for continued investigation. Both strains were isolated from a colony collected from Long 
Island, NY and both were cultured, extracted, and tested in a suite of antimicrobial assays. 
Chromatographic and spectroscopic techniques were utilized to isolate and identify the 
predominant biologically active compounds within each bacterial extract. Additional experiments 
were completed in attempts to induce biosynthetic gene clusters to cause production of 
antimicrobial compounds. The compounds with selective antimicrobial activity and 
correspondingly low toxicity were prioritized as potential leads for novel antibacterial drugs.   
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Introduction  
According to the Centers for Disease Control and Prevention (CDC), in 2016 over two 
million patients in the United States were diagnosed with a bacterial or fungal infection caused by 
a strain resistant to current antibacterial or antifungal treatments, with 23,000 of those cases 
resulting in death (Antibiotic/Antimicrobial Resistance 2017).  More recently, the World Health 
Organization (WHO) has released a list of twelve bacterial families that are becoming increasingly 
virulent, highlighting the global necessity of new drug treatments (Lawe-Davies and Bennett 
2017). Many of these bacterial strains are part of the ESKAPE pathogens group which includes 
Enterrococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, 
Pseudomonas aeruginosa, and Enterobacter spp. (Santajit 2016).  
Acinetobacter baumannii is one of the ESKAPE pathogens that is known to be especially 
antibiotic resistant (Tas et al. 2013). A. baumannii is resistant to three of the major classes of 
antibiotic treatments including carbapanems, aminoglycosides, and tetracyclines (Tas et al. 2013). 
One of the few known antibiotics effective in fighting A. baumannii infections in humans is 
tigecycline, a derivative of tetracycline which prevents protein synthesis in the bacteria by binding 
to 30S ribosomes (Tas et al. 2013). Due to the limited number of effective commercially available 
antibiotics against A. baumannii, treating infections caused by virulent bacterial strains is 
especially difficult. As such, numerous research efforts are aimed at finding treatments for 
infections caused by A. baumannii and the other virulent ESKAPE strains (Pendleton et al. 2014). 
Now more than ever there is a need for new drugs and treatments to combat the bacterial and 
fungal strains that are becoming antibiotic and antifungal resistant at an alarming rate (Santajit 
2016).  
	 9 
There has been increased interest in natural products as a potential source of small 
molecules which are vital to the development and discovery of new drugs (Newman and Cragg 
2012).  The environment has long been a source of therapeutic agents, with plants serving as one 
of the first sources of compounds to be used in new drugs (Newman and Cragg 2012). As time 
passed, scientists began to look at microorganisms and symbiotic communities in the environment 
as potential sources of novel compounds for new drug therapies (Cragg and Newman 2013). One 
notable example of natural products contributing to novel drug therapies is with the discovery of 
penicillin. Penicillin was isolated from Penicillium notatum by Alexander Fleming and when 
tested, was found to have potent antibiotic activity (Seabrooks and Hu 2017). Penicillin is just one 
of the many examples of drugs discovered from microorganisms and symbiotic communities.   
 
 
Figure 1. Defense mechanisms and interactions mediated by symbionts against pathogens, parasites 
and parasitoids (figure from Flórez et al. 2015). 
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 Secondary metabolites that are produced by bacteria and other organisms as part of 
symbiotic communities show great potential for novel antibiotics (Clardy et al. 2009). Most of the 
research that has been conducted in the field of host-microbe relationships has revolved around 
biological investigations of the mutualistic associations between the species involved. More 
recently, the field has expanded to include ground-breaking research on the defensive qualities that 
one or more symbiotic microbes may contribute to the host organism (Flórez et al. 2015). There 
are four main ways in which a symbiotic relationship with microbial partners can benefit a host 
organism: the partners can improve the strength of the host, they can exclude pathogens through 
competition, they can improve the immune system of the host, or they can produce secondary 
compounds which display various levels of bioactivity, thus protecting the organism (Figure 1, 
Flórez et al. 2015).   
One symbiotic community that shows great potential for novel metabolites to combat 
antimicrobial resistance is the Trachymyrmex septentrionalis leaf-cutter ant community. T. 
septentrionalis (Figure 2A) is a leaf-cutter ant species in the tribe Attini that grows a cultivar 
fungus as part of a symbiotic relationship (Scott et al. 2010). The ants provide the nutrients to 
maintain the fungus garden, and in return the fungus garden serves as the primary food source for 
the ants (Scott et al. 2010). The cultivar fungus garden is susceptible to various fungal pathogens, 
such as Escovopsis, which in turn has a harmful effect on the ants. In order to protect against 
pathogens, the symbiotic community has adapted various defense mechanisms (Figure 3, Klassen 
2014).  
One of the most studied mechanisms revolves around the bacteria Pseudonocardia, which 
is housed in crypts on the underside of the ants (Figure 2B). In a mutualistic relationship, the ant 
keeps the bacteria alive, and in turn, the bacteria produce secondary metabolites which help to 
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protect the fungus garden and by association, the ants, from harmful pathogens (Figure 3, Klassen 
2014). Another mutualistic relationship centers on the fungus garden which plays host to various 
bacterial strains, some of which may be transient while others are intrinsically part of the symbiotic 
community. These bacterial strains, similar to Pseudonocardia, possess the capacity to produce 
secondary metabolites which protect the cultivar fungus from fungal pathogens (Barke et al. 2010). 
Additionally, bacterial strains present within fungus gardens have been thought to provide various 
nutrients to the fungus garden, providing an additional benefit to the fungus (Figure 3, Klassen 
2014). 
 
Figure 2. Trachymyrmex septentrionalis, a leaf-cutter ant species that creates a cultivar fungus 
garden and participates in a number host-microbe symbiotic relationships (photos by Mark Smith). 
A B
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Figure 3. Interactions between fungus growing ants and their symbiotic, pathogenic, and   
transient microbes (figure from Klassen 2014). 
Despite the limited research that has been conducted on these fungus-garden associated 
bacterial strains, analysis of their metagenomes has revealed numerous biosynthetic clusters, 
further indicating that these strains possess the capacity to produce secondary metabolites with 
potent bioactivity (Klassen 2014). Additional studies have been conducted in order to determine 
the identities of the main bacterial strains residing within the cultivar fungus. One such study, for 
example, was able to show that the bacteria residing within the fungus garden are primarily gram-
negative species (Scott et al. 2010). 
One common problem in attempting to isolate and identify secondary metabolites as 
sources for novel drugs is that it can be difficult to initiate secondary metabolite production without 
the presence of a challenging microbial strain (Pettit 2009). One such method that this problem 
can be solved is via the use of co-culturing the bacterial strain of interest with a challenging 
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pathogenic bacterial strain (Pettit 2009). Through the introduction of a challenge organism, 
previously silent biosynthetic gene clusters (BGCs) may be activated in the bacterial isolate of 
interest. This allows additional secondary metabolites to be produced in a laboratory which can 
more closely replicate the interactions which are occurring between organisms in the environment 
(Pettit 2009).  
BGCs can be identified in a number of ways, the most recent of which involves the use of 
Antibiotics and Secondary Metabolite Analysis Shell, antiSMASH (Blin et al. 2017). By analyzing 
the genome of a bacterial strain of interest, it is possible to analyze BGCs to determine the capacity 
an organism has for producing secondary metabolites, which can then be used to infer the potential 
biological activity the organism might display (Blin et al. 2017). In addition, the metabolites 
produced through BGCs can be used to perform de-replication. De-replication involves working 
backward towards structure elucidation through the comparison of known compounds in published 
databases (Hubert and Renault 2015).  
Preliminary data from our research (Table 1, Johnkennedy 2016) has shown that a number 
of bacterial isolates from a single T. septentrionalis fungus garden community collected in Long 
Island, New York are biologically active against safe relatives of the ESKAPE pathogens. Based 
on this data, Pseudomonas fluorescens was of interest as this strain displayed inhibitory activity 
against the largest number of pathogenic strains in the assays performed (Johnkennedy 2016). 
Three Delftia tsuruhatensis strains were also of interest due to their selective inhibition of bacterial 
strains using the cross-streak assay. Specifically, only strains JKS566 and JKS571 inhibited 
Acinetobacter baylyli, while strains JKS571 and JKS582 showed inhibition against 
Staphylococcus epidermidis and Pseudomonas putida.  
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Strain 
ID 
16 rRNA ID Erwinia 
carotovora 
Enterococcus 
raffinosus 
Bacillus 
subtilis 
Staphyloccus 
epidermidis 
Escherichia 
coli 
Acinetobacter 
baylyi 
Pseudomonas 
putida 
Enterobacter 
aerogenes 
Gram 
Stain 
 Negative Positive Positive Positive Negative Negative Negative Negative 
JKS 
572 
Agrobacterium 
tumefaciens 
0 0 0.5 0 0 0 0 0 
JKS 
574 
Agrobacterium 
tumefaciens 
0 0 0 0 0 0 0 0 
JKS 
581 
Agrobacterium 
tumefaciens 
0 0 0 0 0 0 0 0 
JKS 
585 
Agrobacterium 
tumefaciens 
0 1 0 1 0 0 0 0 
JKS 
588 
Agrobacterium 
tumefaciens 
0 0 0 0 0 0 0 0 
JKS 
591 
Agrobacterium 
tumefaciens 
0 0 0 0 0 0 0 0 
JKS 
576 
Cupriavidus 
metallidurans 
0 0 0 0 0 0 0 0 
JKS 
579 
Cupriavidus 
metallidurans 
0 0 0 0 0 0 0 0 
JKS 
586 
Cupriavidus 
metallidurans 
0 1 0 0 0 0 0 0 
JKS 
589 
Cupriavidus 
metallidurans 
0 0 0 0 0 0 0 0 
JKS 
592 
Cupriavidus 
metallidurans 
0 0 0 1 0 0 0 0 
JKS 
566 
Delftia 
tsuruhatensis 
0 0 0 0 0 1 0 0 
JKS 
571 
Delftia 
tsuruhatensis 
0 0 0 1 0 1 0.5 0 
JKS 
583 
Delftia 
tsuruhatensis 
0 0 0 1 0 0 1 0 
JKS 
573 
Herbaspirillum 
huttiense 
0 0 0 0 0 0 0 0 
JKS 
577 
Herbaspirillum 
huttiense 
0 0 0 0 0 0 0 0 
JKS 
587 
Herbaspirillum 
huttiense 
0 0 0 0 0 0 0 0 
JKS 
593 
Herbaspirillum 
huttiense 
0 0 0 0 0 0 0 0 
JKS 
570 
Pantoea sp. 0 1 0 0 0 0 0 0 
JKS 
582 
Pseudomonas 
fluorscens 
0 0 1 1 1 1 1 1 
JKS 
584 
Pseudomonas 
orientalis 
0 1 1 1 0 1 0 0 
JKS 
569 
Ralstonia 
insidiosa 
0 0 1 1 0 0 0 0 
JKS 
568 
Sphingomonas 
sp. 
0 1 0 0 0 0 0 0 
JKS 
590 
Sphingomonas 
sp. 
0 0 0 0 0 0 0 0 
JKS 
594 
Variovorax sp. 0 0 0 0 0 0 0 0 
JKS 
565 
Unknown 0 1 0 0 0 0 0 0 
JKS 
567 
Unknown 0 0 0 0 0 0 0 0 
JKS 
575 
Unknown 0 0 1 1 0 0 0 0 
 
Table 1. Inhibitory activity of colony 62 bacterial isolates against safe relatives of the ESKAPE 
pathogens modified from Johnkennedy (2016). 
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This University Scholar and Honors thesis project follows three primary aims: I) determine 
the antibacterial, antifungal, and anti-proliferative properties of the P. fluorescens and D. 
tsuruhatensis bacterial extracts from the T. septentrionalis community; II) isolate and elucidate the  
structures of secondary metabolites extracted from these bioactive bacteria; and III) a genomic 
analysis to annotate BGCs providing an understanding of the production of the secondary 
metabolites by the biologically active bacterial strains. We hypothesized that the bioactive 
bacterial strains were producing secondary metabolites to combat pathogens in nature, and those 
metabolites could be applied toward protecting against human pathogens as well. Additionally, we 
hypothesized that through the use of co-culture experiments, the production of secondary 
metabolites would be upregulated and there would be increased biological activity.  
 
Experimental  
General experimental 
 All media were purchased from Difco and prepared using Millipore water and autoclaved 
for sterility. Reagents and solvents were purchased from Sigma-Aldrich. A. baumannii (ATCC 
19606), methicillin sensitive S. aureus (ATCC BAA-1718) P. aeruginosa (ATCC 15442), and B. 
subtilis (ATCC 6051) were used in bioassays, challenge experiments, and cross-streak assays. 
Liquid chromatography-mass spectrometry (LC-MS) was conducted via an Agilent ESI single 
quadrupole mass spectrometer with an Agilent high performance liquid chromatography (HPLC) 
system with an Agilent C18-XDB (4.6 x 150 mm) column. 
 
Bacterial isolate collection 
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  The T. septentrionalis colony was collected by the Klassen Laboratory (UConn Molecular 
and Cell Biology) and bacterial strains from the fungus garden were previously isolated 
(Johnkennedy 2016). Briefly, a T. septentrionalis fungus garden colony was collected from Robert 
County Park in Long, Island NY. In order to isolate bacterial strains from the fungus garden, a 
sample of the fungus garden was suspended in phosphate-buffered saline (PBS) and serial dilutions 
from 100 to 10-5 were performed. Spread plates for each dilution were then prepared with tryptic 
soy agar (TS agar), eosin methylene blue agar, MacConkey agar and Lactococcus-selective agar 
all containing antifungal chemicals to prevent the fungus garden from continuing to grow and 
allowing the bacterial strains to grow. Individual strains were isolated and pure cultures of each 
strain were created (Johnkennedy 2016). 
 
Culturing of bacterial isolates  
 All bacterial isolates were cultured to 1 L with tryptic soy broth (TS broth). The bacterial 
strains were streaked onto TS agar on day one. Twenty-four hours later, 5 mL of TS broth was 
inoculated with a single bacterial colony and incubated for three days at 28 ºC shaking at 200 rpm. 
On day three, 1.5 mL of the liquid culture was transferred to 50 mL of fresh TS broth in a 125 mL 
sterile baffled flask and incubated for another three days at 28 ºC at 200 rpm. On day six, 15 mL 
of the 50 mL liquid culture was transferred to 500 mL of fresh TS broth in a 1 L baffled flask. Two 
1 L baffled flasks, with 500 mL of media in each flask, were cultured for a total culture volume of 
1 L. Flasks were incubated at 28 ºC at 200 rpm. On day nine, extraction began. 
 
Extraction 
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 Cultures were sonicated to lyse cells and then were transferred to Erlenmeyer flasks. Pre-
rinsed HP20 diaion beads (Supelco) were added to the cultures in a 10% weight/volume ratio. 
Cultures and beads were incubated at room temperature for 24 hours shaking at 125 rpm. The 
cultures and beads were then transferred to a 600 mL frit filter and washed with Millipore water 
(2x 300mL). The beads were then sequentially washed with methanol (MeOH), dichloromethane 
(DCM) and acetone (2x 300 mL per solvent). The organic washes were combined and concentrated 
using a rotary evaporator. The organic portion was further extracted with ethyl acetate to remove 
residual aqueous soluble material, then concentrated with a rotary evaporator.  
 
Liquid chromatography-mass spectrometry (LC-MS) 
 Using the Agilent LC-MS, a solvent gradient of 40-100% ACN with 0.1% FA was used 
(LC-MS_Extract). A method of 25-100% ACN with 0.1% FA and Millipore water with 0.1% FA 
over 75 minutes (LC-MS_Extract_Long) was also used to analyze the samples. Additionally, a 
modified gradient method of 5-50% ACN with 0.1% FA and Millipore water with 0.1% FA over 
45 minutes was used to visualize any potential compounds eluting with the original solvent front 
from the LC-MS_Extract or LC-MS_Extract_Long gradient methods. Injection volume of 25 µL 
was used for all gradients and all samples were prepared to 1 mg/mL in HPLC grade MeOH.  
 
Nuclear magnetic resonance 
Proton Nuclear magnetic resonance (1H NMR) was obtained using a Bruker AVANCE 500 
MHz spectrometer (500.13 MHz). Samples were dissolved in 600 µL of deuterated chloroform 
(CDCl3) and transferred to an NMR tube. If the extract did not fully dissolve in CDCl3, deuterated 
methanol (CD3OD) was used as the alternate solvent. NMR spectra were subsequently calibrated 
	 18 
and phased using MestReNova. Additional integration and peak assignment was also performed 
using MestReNova. Tetramethylsilane (TMS) was used as the internal reference.  
To obtain NMR for pure samples of compound 1 and compound 2, compound 1 was 
dissolved in 300 µL of CDCl3 in Shigemi NMR tubes standardized to CDCl3 while compound 2 
was dissolved in 600 µL of CD3OD . 
 
Solid Phase Extraction (SPE) 
Solid phase extraction (SPE) was used to fractionate extracts using Discovery DSC SPE 
columns with varying solvent gradients to separate compounds based on polarity. Four solvent 
systems were created with ACN and Millipore water: 15% ACN, 25% ACN, 50% ACN, and 100% 
ACN. Each solvent system corresponded to fraction A, B, C, and D respectively. A small amount 
of solution (less than 1 mL) was added to the sample and sonicated. The portion of sample that 
dissolved into solution was added to the SPE column and pushed through the column with the 
remaining amount of solvent. This was repeated for each solvent system and each fraction was 
subsequently analyzed via LC-MS and 1H NMR to identify possible compounds of interest and/or 
known metabolites. 
 
High performance-liquid chromatography (HPLC) 
 High performance-liquid chromatography (HPLC) was used to isolate the compounds of 
interest identified via LC-MS chromatograms and 1H NMR of the SPE fractions. To isolate 
compound 1, an isocratic elution of 15% ACN 85% Millipore water at 1 mL/min was used, with 
the compound eluting from the column at 14 minutes. An isocratic elution of 70% ACN 30% 
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Millipore water at 1 mL/min was used to isolate compound 2, which eluted from the column at 15 
minutes. An Agilent C18-XDB column (4.6 x 150 mm) was used for both isolations.  
 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
 Extracts were analyzed via LC-MS/MS on a Waters Synapt G2 Si at the UConn Proteomics 
and Metabolomics Facility or on a Waters Xevo coupled to an Acquity UPLC system with an 
Acquity UPLC HSS T3 column (2.1 x 150 mm, 1.8 µM) at a flow rate of 0.45 mL/min. LC-MS/MS 
was obtained with extracts prepared at 1 µg/mL in 50% Millipore water 50% LCMS grade MeOH. 
A mobile phase of A (Millipore water with 0.1% FA) and B (ACN with 0.1% FA) was used. The 
gradient elution began with 5% phase B for 0.5 min, increased to 60% B over 3.5 min, increased 
to 98% B over 4 min, and remained at 98% B for 1.2 before returning back to 5% B for 1.8 min. 
All data was obtained using data dependent acquisition with a positive MS survey scan ranging 
from m/z 50-2000, followed by 5 data-dependent MS/MS scans of ions with an intensity greater 
than 1000 from the first scan. 
 
Co-culture experiments  
 A ten-day co-culture experiment was performed (modified from Sung et al. 2017). On day 
zero, 5 mL of sterile TS broth in a 24 deep-well plate was inoculated with one colony of the fungus 
garden bacterial isolate and incubated at 28 ºC shaking at 200 rpm. On day two, the challenge 
organism, A. baumannii was streaked onto TS plates and incubated at 35 ºC. On day three, the 
optical density (OD600) of the bacterial isolate inoculum was recorded and 1 mL of inoculum was 
added to two 125 mL baffled flasks with 25 mL fresh TS broth. Also on day three, 5 mL of nutrient 
broth was inoculated with a colony of A. baumannii and incubated at 28 ºC shaking at 200 rpm. 
	 20 
On day four, the OD600 of the A. baumannii inoculum was recorded and 200 µL was added to one 
of the 125 mL of bacterial isolate inoculum and another 125 mL baffled flask containing fresh 25 
mL nutrient broth. Cultures were incubated at 28 ºC for six days shaking at 200 rpm. On day ten, 
each culture was extracted according to the normal extraction protocol but washed with 2 x 30 mL 
of each solvent (Millipore water, MeOH, DCM, acetone). 
    
Bioassays 
 Anti-bacterial and anti-fungal assays followed Clinical and Laboratory Standard 
Guidelines (2012) and were modified from Zgoda et al. (2011) for use with natural products. 
Briefly, a bacterial inoculum of each bacterial pathogen was prepared and adjusted to OD600 0.08-
0.10. Each well contained the bacterial inoculum, TS broth for S. aureus or nutrient broth for A. 
baumannii, and extracts or controls [DMSO was used as the negative control, vancomycin (S. 
aureus) or gentamicin (A. baumannii) were used as the positive controls]. Plate readings were 
taken at 0h and 24h for S. aureus and at 0h and 8h for A. baumannii with a Synergy H1 plate 
Reader. All extracts tested were prepped to 50 mg/mL in Dimethyl sulfoxide (DMSO) for a final 
testing concentration of 250 µg/mL. 
Cytotoxicity assays were conducted against MCF-7 breast cancer cells as previously 
described (Gromek et al. 2016). Cells were seeded at 3000 cells/well and incubated for 24 h. Cells 
were treated with extracts or DMSO (negative control) or 10 µM doxorubicin (positive control) 
and incubated for 72 h. Following incubation, 3-(4,5-Dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and phenazine methosulfate 
(PMS) were added and incubated for 3 hours. Absorbance was read at 490 nm using the Synergy 
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H1 plate reader. All bioassays (antibacterial and anti-proliferative) were conducted in 96 well flat-
bottom plates purchased from Costar.  
 
Molecular networking 
LC-MS/MS data was converted to mzML format with Proteowizard and uploaded into 
GNPS: Global Natural Products Social Molecular Networking (http://gnps.ucsd.edu). Files were 
then imported into Cytoscape 2.8.3, arranged with FM3 layout, node colors mapped based on 
source files, and edge thickness defined to reflect cosine similarity scores (thicker edge lines 
indicate increased similarity). Minimum cosine score was set to 0.65.  
 
Cross-streak of fungus garden bacterial isolates with challenge organisms 
  The fungus garden bacterial isolates were cross-streaked with S. aureus, A. baumannii, B. 
subtilis, and P. aeruginosa. On day one, fungus garden bacterial isolates were streaked onto TS 
agar and incubated overnight at 28 ºC. On day two, 5 mL of TS broth was inoculated with a single 
fungus garden bacterial colony and incubated overnight shaking at 200 rpm at 28 ºC. On day three, 
these strains were streaked down the middle of a TS plate. Control plates for each fungus garden 
strain were made with inoculum spread over the entire plate. Also on day three, the pathogenic 
organisms S. aureus, B. subtilis, and P. aeruginosa were streaked onto TS plates while A. 
baumannii was streaked onto a nutrient plate and all plates incubated at 35 ºC overnight. On day 
four, 5 mL of either TS broth (S. aureus, B. subtilis, and P. aeruginosa) or nutrient broth (A. 
baumannii) were inoculated with a single bacterial colony and incubated at 28 ºC overnight while 
shaking at 200 rpm. On day five, the pathogenic organisms were streaked onto the plates 
containing each fungus garden bacterial isolate. Two bacterial strains were streaked on each side 
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of the fungus garden strain, for a total of four challenge organisms per plate (Figure 13). Each plate 
was performed in triplicate and control plates for each challenge bacterial strain were streaked. 
Plates were incubated overnight at 28 ºC. On day six, plates were analyzed for areas of inhibition 
and analyzed every 24 hours until they appeared.  
 
Agar extractions 
When areas of inhibition appeared in the cross-streak plates described above, the agar was 
cut around the area of inhibition. Using a spatula, the zone of clearing was isolated from the plate 
to make sure that the remaining bacterial strains were not cut out with the area of inhibition. The 
agar pieces cut from the plate were cut into smaller pieces and extracted with 2:1 ethyl 
acetate:MeOH in an Erlenmeyer flask. Extracts were sonicated and placed at room temperature for 
30 minutes before solvent was filtered from agar pieces using a Buchner funnel. Following 
filtration, agar pieces were returned to the Erlenmeyer flask and placed in 2:1 ethyl acetate: MeOH 
solution. The flask was sonicated for an additional 30 seconds and sat at room temperature 
overnight, after which 3:2:1 water: ethyl acetate: MeOH was added. Water was used to obtain any 
aqueous soluble compounds from the agar pieces. The flask was sonicated again and sat for 30 
minutes at room temperature, after which agar pieces were filtered. Aqueous and organic portions 
were separated with a separatory funnel and organic portions were dried down using a rotary 
evaporator. Aqueous portions were freeze-dried using a Labconco lyophilizer.  
 Control extracts were also made for TS agar, nutrient agar, as well as monocultures of 
JKS566, JKS571, A. baumannii, S. aureus, P. aeruginosa, and B. subtilis. These control extracts 
were extracted similarly, except the whole plate of agar was extracted.  
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Antibiotics and secondary metabolite analysis shell (antiSMASH) 
 Genomes for the D. tsuruhatensis fungus garden strains were sequenced and assembled by 
the Klassen Laboratory. Assembled genomes were analyzed using antiSMASH 3.0.5 to detect 
BGCs capable of producing secondary metabolites (Weber et al. 2015).  
 
Results/Discussion 
 Pseudomonas fluorescens and the three Delftia tsuruhatensis strains were chosen for 
further analysis based on their inhibitory activity in a preliminary cross-streak analysis (Table 1). 
P. fluorescens was chosen as it was able to inhibit the most pathogenic bacterial strains compared 
with other fungus garden bacterial isolates. The three D. tsuruhatensis strains were of interest due 
to the selective inhibition displayed by the three different strains (Table 1). Two of the D. 
tsuruhatensis strains, JKS566 and JKS571, were able to inhibit Acinetobacter baylyi, while 
JKS571 and JKS583 inhibited Staphylococcus epidermidis and Pseudomonas putida. These four 
fungus garden bacterial strains were cultured in liquid media and extracted as described above.  
 
Pseudomonas fluorescens 
 The P. fluorescens crude extract was first analyzed via LC-MS using the LC-MS_Extract 
gradient and showed a prominent peak of absorbance in 254 nm at an elution time of 8 minutes 
(Figure 4). Additionally, following SPE fractionation, this peak was evident in fractions A and B 
(Figure 5). Through HPLC, the compound was isolated as compound 1 and LC-MS/MS was 
obtained to indicate an [M+H]+ of 225.0647 Da (Figure 6). In order to further elucidate the 
structure of the compound, 1H NMR (CDCl3) was obtained (Figure 7). Based on the chemical 
shifts and molecular weight, the compound was determined to be a known compound, phenazine-
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1-carboxylic acid (PCA), due to similarity of previously published data (Mehnaz et al. 2013). PCA 
has been known to possess a wide range of antimicrobial properties (Rane et al. 2007). Thomashow 
and Weller (1988) were among the first to attribute PCA of possessing antimicrobial properties by 
discovering that PCA and P. fluorescens provided protection against wheat pathogens. Most 
commonly, PCA is isolated from Pseudomonas strains from various plant rhizospheres, indicating 
that PCA plays a role in protection against root pathogens (Xu et al. 2015).  
 
Figure 4. LC-MS chromatogram for the Pseudomonas fluorescens crude extract with a solvent 
gradient of 40-100% acetonitrile (ACN) with 0.1% formic acid (FA) and Millipore water over 
30 minutes with a 5-minute hold time at 100% ACN.    
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Figure 5. LC-MS chromatograms for fractions A-D of the Pseudomonas fluorescens extract with 
a solvent system of 40-100% acetonitrile (ACN) with 0.1% formic acid (FA) and Millipore water 
over 30 minutes with a 5-minute hold time at 100% ACN. 
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Figure 6. LC-MS/MS for compound 1, isolated from fractions A and B of the Pseudomonas 
fluorescens extract, with an [M+H]+ of 225.0647, confirming the production of phenazine-1-
carboxylic acid (224.0585 g/mol). 
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Figure 7. 1H NMR Spectrum (in CDCl3) and structure of compound 1, isolated from 
Pseudomonas fluorescens. 
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Figure 8. LC-MS/MS for Compound 2, isolated from fractions C and D of the Pseudomonas 
fluorescens extract, with a predicted [M+H]+ of 627.4005.  
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Figure 9. 1H NMR Spectrum (in CD3OD)  of compound 2, isolated from Pseudomonas 
fluorescens.   
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The other prominent peak from LC-MS of the P. fluorescens crude extract was compound 
2, eluting at a retention time of 30 minutes (Figure 4). Additionally, this peak was prominent in 
both fractions C and D (Figure 5). Through HPLC, compound 2 was isolated from these fractions. 
Following isolation, LC-MS/MS was obtained (Figure 8) as well as the 1H NMR spectrum in 
CD3OD (Figure 9). Based on the LC-MS/MS, the [M+H]+ of the compound is believed to be 
627.4005 Da and potentially undergoing dimerization based on the cluster of peaks seen at 
1253.7968 Da. When running the [M+H]+ of 627.4005 Da through antibase, there were no 
matches. Additionally, after searching the METLIN (The Scripps Research Institute) database 
(http://xcmsonline.scripps.edu) for a [M+H]+ of 627.4005 Da, there were numerous matches found 
(Table 2).  Structure elucidation is currently ongoing to finalize the structure of compound 2 based 
on the 1H NMR spectra, the METLIN database hits, and the LC-MS/MS data. 
 In addition to isolation and structure elucidation, the bioactivity of compound 1, compound 
2, and the crude extract of P. fluorescens were analyzed. The crude extract for P. fluorescens, 
fractions A-D, compound 1, and compound 2 were tested against S. aureus, A. baumannii, and 
MCF-7 breast cancer cells (Figure 10). The crude extract, fraction A, fraction B, and compound 1 
all moderately inhibited S. aureus, leading us to believe that compound 1 is likely the metabolite 
responsible for the inhibitory activity of the crude extract against S. aureus. While none of the 
extracts for P. fluorescens showed activity against A. baumannii, the crude extract and fractions C 
and D showed very strong anti-proliferative activity (Figure 10). Specifically, the crude extract 
resulted in cell viabilities of 1.5 % while fractions C and D resulted in cell viabilities of 0.5 % and 
0.9 % respectively. Compound 2 also displayed strong anti-proliferative activity, providing 
evidence that this compound was likely responsible for the anti-proliferative activity seen against 
MCF-7 breast cancer cells in the crude extract and fractions C and D.  
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Figure 10. Antibacterial and anti-proliferative activity of Pseudomonas fluorescens extract 
(MB0316), fractions (A-D), compound 1, and compound 2 against S. aureus, A. baumannii, and 
MCF-7 breast cancer cells. 
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Table 2. METLIN matches for [M+H]+ masses of compound 2, isolated from P. fluorescens. 
M+H  M Metlin ID XCMS Hit ∆ ppm  
627.4020 626.3948 81245 PA(13:0/18:4(6Z,9Z,12Z,15Z)) 2 
627.4020 626.3948 81590 PA(18:4(6Z,9Z,12Z,15Z)/13:0) 2 
627.3985 626.3913 941816 1,1'-(Hexadecane-1,16-diyl)dipyrene 3 
627.3972 626.3899 65448 Somocystinamide A byproduct 5 
627.4049 626.3976 926949 L-Prolyl-N~5~-(diaminomethylidene)-L-
ornithyl-L-lysyl-N~5~-(diaminomethylidene)-
L-ornithyl-L-alanine 
7 
627.4049 626.3976 926943 L-Alanyl-L-lysyl-L-prolyl-N~5~-
(diaminomethylidene)-L-ornithyl-N~5~-
(diaminomethylidene)-L-ornithine 
7 
627.4053 626.3980 971300 5,5'-Bis(4-undecylphenyl)-2,2'-bithiophene 7 
627.4057 626.3985 896157 2,4-Bis{bis[4-
(dimethylamino)phenyl]methyl}-3,6-
dimethylphenol 
8 
627.3950 626.3877 94139 Sucrose monostearate 8 
627.3950 626.3877 558180 Octadecanoic acid--4-O-hexopyranosylhexose 
(1/1) 
8 
627.3939 626.3866 45386 15-deoxy-Δ12,14-Prostaglandin J2-biotin 10 
627.4090 626.4017 521610 Strontium heptadecanoate 13 
627.4103 626.4030 84221 (25R)-5alpha-spirostan-3beta,6alpha,23S-triol 
6-O-beta-D-glucopyranoside 
15 
 
Delftia tsuruhatensis 
 For the three D. tsuruhatensis strains, a molecular network was created using the LC-
MS/MS data of the extracts in attempts to determine potential compounds found only in JKS566 
and JKS571, which could thus be the compounds responsible for the initial A. baylyi inhibition 
(Figure 11). In the network, compounds extracted from JKS566 are represented with yellow 
circles, compounds from JKS571 are represented with blue circles, and compounds found in both 
those strains are represented by green squares. All nodes containing compounds from the third 
Delftia strain (JKS583), are colored grey. In this molecular network, the green squares indicate 
potential compounds responsible for the A. baylyi inhibition. When compared to the GNPS 
database (http://gnps.ucsd.edu), several compounds in the clusters have been putatively identified 
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including 1,3-dimethyluric acid, catechol, and monoerucin. However, there were numerous nodes 
with no matches within the database, increasing the potential for identifying novel compounds. 
  
Figure 11. Molecular network of Delftia tsuruhatensis fungus garden extracts to identify 
compounds unique to JKS566 and JKS571, the two strains which selectively inhibited 
Acinetobacter baylyi in preliminary tests. Compounds highlighted are known compounds from the 
GNPS database that could potentially be responsible for the inhibitory activity.  
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Figure 12. Antibacterial and anti-proliferative activity of Delftia tsuruhatensis extracts (MB0598 
(JKS583), MB0658 (JKS566), MB0667 (JKS571)) and Delftia tsuruhatensis and A. baumannii 
co-culture extracts (MB0657 (JKS566) and MB0666 (JKS571)) against S. aureus, A. baumannii, 
and MCF-7 breast cancer cells.  
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The bioactivity of the D. tsuruhatensis extracts was also tested in 96 well bioassays. 
Despite the preliminary data showing that JKS566 and JKS571 inhibited the safe relative of A. 
baumanni (A. baylyi), extracts from JKS566 (MB0658) and JKS571 (MB0667) showed no 
inhibition against A. baumannii (Figure 12). Additionally, despite inhibiting S. epidermidis in the 
preliminary data, the JKS583 extract (MB0598) actually showed increased growth of S. aureus. 
These observations led us to hypothesize that there may be silent biosynthetic gene clusters in the 
D. tsuruhatensis strains, and if challenged with a pathogenic organism these gene clusters might 
be activated to produce bioactive secondary metabolites.  
 JKS566 and JKS571 were chosen to perform co-culture experiments with. Both strains 
were challenged with A. baumannii over a 10-day period. Neither the co-culture of JKS566 and A. 
baumannii (MB0657) nor the co-culture of JKS571 and A. baumannii (MB0667) resulted in 
modified bioactivity compared with the monoculture extracts (Figure 12). There was no inhibition 
seen with the co-culture extracts against S. aureus, A. baummannii, or MCF-7 breast cancer cells 
despite our original hypothesis that co-culturing would increase activity. 
Due to the lack of activity in bioassays, agar extractions were planned in an attempt to 
directly extract metabolites from the agar that were secreted by the bacterial strains. A cross-streak 
was performed with JKS566 and JKS571 against S. aureus, A. baumannii, P. aeruginosa, and B. 
subtilis. Over a six-day period, the fungus garden strains were cross-streaked with the human 
pathogens (Figure 13). Both JKS566 and JKS571 considerably inhibited A. baumannii, with one 
plate from each strain showing almost complete inhibition (Figure 14). The observation that both 
JKS566 and JKS571 only inhibit A. baumannii in the presence of three other challenge organisms 
highlights a potential interaction that is occurring between one or more of the four pathogenic 
strains and the D. tsuruhatensis strain that is either strengthening D. tsuruhatensis or weakening 
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A. baumannii. The areas of inhibition seen on each agar plate from the cross-streaks were cut and 
removed from the plate and extracted in order to analyze the antimicrobial secondary metabolites 
in the agar. 
 
Figure 13. Plate map for cross-streak assay of Delftia tsuruhatensis fungus garden strains against 
MSSA, A. baumannii, P. aeruginosa, and B. subtilis.  
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Figure 14. Results of cross-streak assays showing areas of inhibition for JKS566 and JKS571 
against A. baumannii. Black arrows highlight the areas of inhibition of A. baumannii caused by 
JKS571 (A) and JKS566 (B). One plate (plate 3, row A) was incorrectly plated due to experimental 
error with all strains on opposite sides. 
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Figure 15. Molecular network comparing agar extracts from areas of inhibition from JKS566 and 
JKS571 cross-streak assays to a media control to identify potential antimicrobial compounds 
unique to the areas of of inhibition seen against Acinetobacter baumannii. 
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Table 3. Biosynthetic gene clusters identified in the Defltia tsuruhatensis JKS566 genome using 
antibiotics and secondary metabolite analysis shell (antiSMASH). 
Cluster Type Most Similar Known Cluster  Percent 
Similarity  
Molecular Weight 
(g/mol) 
34 unknown Pyrrolomycin 5% 180.972 
7 T2pks Actinorhodin 9% 634.546 
26 unknown PM100117/PM100118 10% 1584.913/1562.913 
12 unknown Griseobactin 11% 1179.5 
23 unknown Amphotericin 23% 924.079 
27 cf_fatty_acid Lipopolysaccharide 25% 4899.956 
24 cf_saccharide Lipopolysaccharide 33% 4899.956 
10 unknown Polyhydroxyalkanoate  75% N/A 
18 T1pks-Nrps Delftibactin 100% 1033.064 
 
Table 4. Biosynthetic gene clusters identified in the Delftia tsuruhatensis JKS571 genome using 
antibiotics and secondary metabolite analysis shell (antiSMASH). 
Cluster Type Most Similar Known 
Cluster  
Percent 
Similarity  
Molecular Weight 
(g/mol) 
34 unknown Pryyolomycin 5% 180.972 
7 T2pks Actinorhodin 9% 634.546 
17 unknown Amphotericin 23% 924.079 
20 Cf_fatty acid Lipolysaccharide 25% 4899.956 
18 cf_saccharide Lipolysaccharide 33% 4899.956 
27 T1pks-nrps Delftibactin 100% 1033.064 
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Table 5. Biosynthetic gene clusters identified in the Defltia tsuruhatensis JKS583 genome using 
antibiotics and secondary metabolite analysis shell (antiSMASH). 
Cluster Type Most Similar Known 
Cluster  
Percent Similarity  Molecular Weight 
(g/mol) 
1 unknown Lipopolysaccharide  5% 4899.956 
5 unknown Pyrrolomycin 5% 180.972 
27 T2pks Actinorhodin 9% 634.546 
12 unknown Mycosubtilin 20% 1199.375 
8 unknown amphotericin 23% 924.079 
3 cf_fatty_acid lipopolysaccharide  25% 4899.956 
9 cf_saccharide lipopolysaccharide  33% 4899.956 
30 unknown Polyhydroxyalkanoate 75% N/A 
34 T1pks-Nrps Delftibactin 100% 1033.064 
 
LC-MS/MS was obtained for each of the extracts created from the cross-streak assay. A 
molecular network was created in order to identify the masses of the compounds which are unique 
only to the area of extract and are not media components or secondary metabolites from the 
individual bacterial strains secreted in the absence of the of the challenge organisms (Figure 15). 
In the network, yellow circles represent compounds found in the three agar extracts from the 
JKS566 inhibition of A. baumannii, blue circles represent the compounds found in the three agar 
extracts from the JKS571 inhibition of A. baumannii, while green squares represent compounds 
found in all of the zone of inhibition extracts. Nodes in grey contain components found in the 
media control. There were a total of 103 compounds found in only the zone of inhibition extracts, 
indicating that there are a number of compounds potentially responsible for the inhibitory activity 
seen in the cross-streak assays.  Further de-replication and structure elucidation will be performed 
to identify the antimicrobial compounds. 
Lastly, the genomes of JKS566, JKS571, and JKS583 were subjected to analysis using 
antiSMASH to determine the capacity for producing biosynthetic compounds. Overall, the 
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antiSMASH data show that the three strains possess the capacity to produce a wide range of 
compounds (Tables 3-5). The three strains (Tables 3-5) show potential to produce compounds in 
a number of structural categories including bacteriocins, non-ribosomal peptide synthetase 
(NRPS), and type one and type two polyketide synthase (T1PKS and T2PKS). Interestingly, 
among all three genomes, there was 100% similarity to the delftibactin gene cluster, from the 
T1PKS-NRPS class. However, when searching through the LC-MS chromatograms for all three 
D. tsuruhatensis strains, we were unable to verify the presence of this compound. Further research 
is needed to determine whether this compound is found within this system as prior research has 
shown this compound to be responsible for gold bio-mineralization (Johnston et al. 2013). Despite 
the known and matched gene clusters within the three genomes, there were still a number of 
unknown compounds capable of being produced by all three strains.  
 
Conclusion  
Based on the antiSMASH analysis and the bioactivity of the fungus garden bacterial 
strains, bacterial strains found within the T. septentrionalis community possess the capacity to 
secrete secondary metabolites. These secondary metabolites show potential for treatments against 
human pathogens. Secondary metabolites produced by the fungus garden bacterial isolates likely 
serve to protect the fungus garden from microbial pathogens from the environment. Once isolated, 
the secondary metabolites from the fungus garden bacterial strains show potential to serve as novel 
antibiotics or anti-cancer drugs. Our results indicate that compound 1 was able to inhibit S. aureus, 
making it a candidate for a future antibiotic development and compound 2 was able to reduce 
proliferation of MCF-7 breast cancer cells, making it a candidate for a potential anti-cancer agent. 
Based on the growing number of bacterial strains displaying resistance to current antibiotic 
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treatments (Lawe-Davies and Bennett 2017), these compounds offer hope of new treatments to 
fight antibiotic resistant strains.  
 Further isolation and structure elucidation of the fungus garden bacterial extracts might 
identify more compounds to be used as potential therapeutic agents. Additionally, the compounds 
and extracts can be tested for additional activity against other human pathogens and cancer cell 
lines. Future experiments can also look at the timing of the co-culture experiments to determine 
the optimal time and length at which the challenge organism should be added to induce the 
production of the greatest amount of antimicrobial metabolites. Additional experiments to analyze 
genomes of fungus garden bacterial strains and attempts to activate silent biosynthetic gene 
clusters will provide more insight in the host-microbe symbiotic relationship found within the T. 
septentrionalis community and how the microbes associated with the ants provide a protective 
advantage.   
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